The Centre of Inflammation and Metabolism and the Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Center for Clinical Research and Prevention, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
Br J Sports Med. 2020 Oct;54(20):1195-1201. doi: 10.1136/bjsports-2018-100393. Epub 2019 Aug 12.
To systematically review and analyse studies of high amounts of physical activity and mortality risk in the general population.
Inclusion criteria related to follow-up (minimum 2 years), outcome (mortality from all causes, cancer, cardiovascular disease (CVD) or coronary heart disease), exposure (eg, a category of >1000 metabolic equivalent of task (MET) min/week), study design (prospective cohort, nested case control or case-cohort) and reports of cases and person years of exposure categories.
Systematic searches were conducted in Embase and Pubmed from database inception to 2 March 2019.
The quality of the studies was assessed with the Newcastle-Ottawa scale.
From 31 368 studies identified, 48 were included. Two authors independently extracted outcome estimates and assessed study quality.
We estimated hazard ratios (HRs) using random effect restricted cubic spline dose-response meta-analyses. Compared with the recommended level of physical activity (750 MET min/week), mortality risk was lower at physical activity levels exceeding the recommendations, at least until 5000 MET min/week for all cause mortality (HR=0.86, 95% CI 0.78 to 0.94) and for CVD mortality (HR=0.73, 95% CI 0.56 to 0.95).
The strengths of this study include the detailed dose-response analyses, inclusion of 48 studies and examination of sources of heterogeneity. The limitations include the observational nature of the included studies and the inaccurate estimations of amount of physical activity.
Compared with the recommended level, mortality risk was lower at physical activity levels well above the recommended target range. Further, there was no threshold beyond which lifespan was compromised.
PROSPERO CRD42017055727.
系统地回顾和分析大量身体活动与普通人群死亡率风险的研究。
与随访(至少 2 年)、结局(全因死亡率、癌症死亡率、心血管疾病死亡率或冠心病死亡率)、暴露(如,1000 个代谢当量任务(MET)分钟/周以上的某一类别)、研究设计(前瞻性队列研究、巢式病例对照研究或病例-队列研究)以及报告病例数和暴露类别人年相关的纳入标准。
从数据库建立开始到 2019 年 3 月 2 日,在 Embase 和 Pubmed 中进行了系统检索。
使用纽卡斯尔-渥太华量表评估研究质量。
从确定的 31368 项研究中,纳入了 48 项研究。两位作者独立提取结局估计值并评估研究质量。
使用随机效应限制立方样条剂量反应荟萃分析来估计危险比(HRs)。与推荐的体力活动水平(750 MET 分钟/周)相比,体力活动水平超过推荐水平时,死亡率风险较低,至少在 5000 MET 分钟/周时全因死亡率(HR=0.86,95%置信区间 0.78 至 0.94)和心血管疾病死亡率(HR=0.73,95%置信区间 0.56 至 0.95)。
本研究的优势包括详细的剂量反应分析、纳入 48 项研究以及检查异质性来源。局限性包括纳入研究的观察性质和体力活动量的不准确估计。
与推荐水平相比,体力活动水平远高于推荐目标范围时,死亡率风险较低。此外,没有超过该水平就会缩短寿命的阈值。
PROSPERO CRD42017055727。